2024 昆士兰临床指南:早期妊娠丢失(V7)

发布日期:
2024-07-19
英文标题:
Queensland Clinical Guideline: Early pregnancy loss
出处:
昆士兰卫生组织官网
AI大纲:

引言

  • 发生率:约15%的已确认妊娠会发生早期妊娠丢失(EPL)
  • 后果:身体并发症(感染、出血等)和心理并发症(悲伤、抑郁等)
  • 高质量护理的作用:提高护理满意度,减少负面结果,支持患者及家属度过困难时期

临床标准

  • 标准护理:参考昆士兰临床指南标准护理,涵盖隐私、同意等方面

急诊科就诊情况

  • 背景:EPL患者常就诊于急诊科,但心理社会护理和后续随访易被忽视
  • 早期妊娠评估服务(EPAS):减少急诊科停留时间和住院率,改善服务和患者体验
  • 护理提供:个体化护理,多学科参与,减少等待时间,提供支持

血流动力学不稳定

  • 背景:澳大利亚部分孕产妇死亡与异位妊娠破裂有关
  • 复苏:遵循标准急救程序,建立静脉通路等
  • 控制出血:排除异位妊娠后考虑药物治疗
  • 手术干预:针对不同情况进行手术

EPL护理原则

Rh D免疫球蛋白

  • 采集血型和抗体筛查
  • Rh D阴性且无抗体时推荐使用,根据孕周确定剂量,尽快在72小时内使用

组织病理学

  • 送检妊娠产物(POC),排除异位妊娠和妊娠滋养细胞疾病(GTD)
  • 与可能在家流产的患者讨论相关事宜

恢复正常月经周期

  • 正常月经恢复表明EPL并发症解决和管理完成
  • 持续不规则出血需随访检查

持续和随访护理

  • 建立当地随访程序和协议
  • 有GTD时向昆士兰滋养细胞中心登记

EPL后建议

  • 提供书面和口头信息,包括紧急求助情况、随访检查等

心理支持

EPL的独特挑战

  • 突然意外,社会忽视,无正式纪念,原因不明等

沟通

  • 敏感共情交流,认可患者感受,提供实用支持

心理教育

  • 增加知识,减少恐惧焦虑,预防长期并发症

记忆创造

  • 与患者讨论记忆创造选项

随访支持

  • 转介咨询、同伴或社区组织

心理发病率

  • 自杀是孕产妇死亡原因之一,EPL后有多种心理问题风险
  • 风险因素包括精神病史等

预防和支持

  • 主动评估心理状况,个体化护理,考虑风险因素,提供支持信息

评估

确认妊娠和评估

  • 评估血流动力学稳定性
  • 采集病史,包括月经、妊娠史等
  • 检查临床症状和体征
  • 进行血清定量β - hCG检测
  • 体格检查和超声扫描
  • 其他检查,如血常规、血型等

确定妊娠 viability和位置

  • 正常β - hCG水平和变化
  • 超声扫描:经阴道超声(TVS)为金标准
  • 连续β - hCG检测
  • 鉴别区:无统一β - hCG水平定义
  • 正常孕酮水平及作用
  • 联合评估变量

诊断非存活宫内妊娠(IUP)

  • 诊断要求:经验丰富的临床医生和高质量TVS设备
  • 可疑但非诊断性发现
  • TVS诊断标准
  • 重复TVS间隔

未知位置妊娠(PUL)

  • 持续警惕:需专科审查和密切随访
  • 连续β - hCG检测:根据变化判断妊娠情况
  • 孕酮检测:初始值≤2 nmol/L提示非存活妊娠

PUL分类后的结果频率

  • 包括存活IUP、非存活IUP、失败PUL、异位妊娠等结果

其他妊娠结果

  • 完全流产:需排除未诊断的异位妊娠
  • 剖宫产瘢痕妊娠:多学科管理
  • 先兆流产:根据情况随访和使用孕酮

异位妊娠

  • 背景:发生率1 - 2%,未及时诊断和处理可危及生命
  • 临床表现:月经异常、阴道出血等
  • 治疗选择:根据临床情况和患者偏好选择

异位妊娠的危险因素

  • 绝育、既往异位妊娠、输卵管手术等因素增加风险

异位妊娠的管理

Expectant Management

  • Context
    • Early and accurate diagnosis enabled by imaging
    • Up to 70% resolve spontaneously in selected women
    • Higher success with no previous ectopic history
  • Suggested Criteria
    • Haemodynamically stable
    • Low and falling β - hCG (<1500 IU/L initially)
    • Tubal mass <3 cm
    • No pain
    • Minimal pelvic blood on USS
    • No geographical isolation
  • Ongoing Management
    • EPAS follow - up
    • β - hCG every 48 hours for 8 days, then weekly until negative
    • USS if β - hCG not falling or clinically indicated
    • Offer other management if requested or due to complications
  • Advice for Women
    • Risk of tubal rupture
    • Avoid pelvic exam and intercourse in acute phase
    • Avoid pregnancy until mass resolves sonographically
    • Early USS in next pregnancy

Medical Management

  • Methotrexate
    • Context: Folic acid antagonist, prevents cell growth
    • Indications
      • Unruptured, haemodynamically stable ectopic
      • Unusual sites
      • Low initial β - hCG (<5000 IU/L optimal)
      • Normal FBC, electrolytes, and liver function
    • Contra - indications
      • Haemodynamic instability
      • Hypersensitivity
      • Haemoperitoneum
      • Renal/liver disease, etc.
    • Cautions
      • High β - hCG, large ectopic, fetal heart motion, etc.
    • Ongoing Management
      • EPAS follow - up
      • β - hCG as per protocol
      • USS as clinically indicated
      • Refer to maternal - fetal medicine if fetal heart present
  • Advice for Women Post - Methotrexate
    • Side effects: Nausea, tiredness, etc.
    • Cytotoxic precautions
    • Avoid sun, folate, intercourse, alcohol, anti - inflammatories
    • Delay pregnancy 3 months
    • Contraception until follow - up complete
    • Early USS in next pregnancy
    • Return to hospital if symptomatic

Surgical Management

  • Indications
    • Woman's preference
    • Haemodynamic instability
    • Excessive bleeding
    • Failed expectant/medical management
  • Approach
    • Laparoscopy for stable women
    • Laparotomy for haemorrhagic shock
  • Follow - up
    • GP follow - up 2 weeks post - surgery
    • β - hCG monitoring
    • Consider medical treatment or salpingectomy if β - hCG doesn't fall
  • Advice for Women
    • Uncertain optimal interval to next conception
    • Early USS in next pregnancy

非存活宫内妊娠(IUP)的管理

Risk Factors

  • Maternal age
  • Previous miscarriage
  • BMI
  • Maternal conditions (anatomic, endocrinopathy, etc.)
  • Fetal factors (chromosomal, congenital abnormalities)
  • Lifestyle (smoking, alcohol, pollution)

Expectant Management

  • Indications
    • Woman's preference
    • Incomplete miscarriage
    • Lower β - hCG and progesterone increase success
  • Contraindications
    • Suspected GTD
    • Haemodynamic instability
    • IUD
    • High risk of haemorrhage or infection
  • Risk/Benefit
    • Less effective than medical/surgical
    • More bleeding days and amount
    • Similar fertility to medical management
    • Unpredictable timeframe
  • Ongoing Management
    • 7 - 10 - day follow - up
    • β - hCG on day 8
    • USS if clinically indicated
    • Discuss other management options if needed
    • Urinary pregnancy test at 3 - 6 weeks if indicated
  • Advice for Women
    • Access to emergency care
    • Expect bleeding up to 2 weeks
    • Option to choose other management later

Medical Management

  • Indications
    • Woman's preference
    • Missed or incomplete miscarriage
  • Contraindications
    • Suspected GTD
    • Haemodynamic instability
    • High risk of haemorrhage or infection
    • IUD
    • Medical contraindications
  • Risk/Benefit
    • Effective for first - trimester miscarriage
    • More effective than expectant for missed miscarriage
    • Heavier and more prolonged bleeding
  • Regimens
    • Mifepristone and misoprostol for missed miscarriage
    • Misoprostol for incomplete miscarriage
  • Ongoing Management
    • β - hCG on day 1 and 8
    • EPAS follow - up on day 2 and 8
    • USS if clinically indicated
    • Urinary pregnancy test at 3 - 6 weeks if indicated
  • Advice for Women
    • Heavy bleeding, cramping, and potential side - effects

Surgical Management

  • Indications
    • Woman's preference
    • Failed expectant/medical management
    • Haemodynamic instability, etc.
  • Cautions
    • High risk of haemorrhage, previous uterine perforation
  • Risk/Benefit
    • Immediate outcome, less follow - up
    • Standard procedure and anaesthesia risks
  • Cervical Priming
    • Misoprostol before surgery
  • Care Provision
    • Suction curettage under general anaesthetic
    • Analgesia as needed
    • Consider antibiotics and USS
  • Follow - up
    • GP follow - up if needed
    • Check histology results
    • Refer for Rh D negative blood group and recurrent EPL
  • Repeat Curettage
    • Consider hysteroscopy or USS guidance

中期妊娠丢失

Potential Aetiologies

  • Fetal: Chromosomal, congenital abnormalities
  • Maternal: Previous loss, uterine malformations, medical illness, etc.

Presentation

  • Intrauterine fetal death, preterm labour, or membrane rupture

Assessment

  • Swabs, maternal investigations

Care Setting

  • Away from uncomplicated pregnancies
  • Adequate analgesia

Medical Management

  • Appropriate for all gestations
  • Misoprostol or mifepristone + misoprostol for induction
  • Active management of third stage

Surgical Management

  • Suitable up to 14 weeks, may be beyond 16 weeks in some cases

Lactation Suppression

  • Conservative measures, consult professionals if needed

Follow - up

  • Obstetrician appointment
  • Postnatal USS
  • Inform GP, refer for investigations

妊娠滋养细胞疾病(GTD)

Classification

  • Non - neoplastic lesions
  • Molar pregnancies
  • Gestational Trophoblastic Neoplasms

Queensland Trophoblast Centre (QTC)

  • Refer all GTD cases

Clinical Presentation

  • Abnormal vaginal bleeding, incidental finding on ultrasound

Diagnosis

  • USS, quantitative β - hCG, histological examination

Interventions

  • Suction curettage, cervical priming, USS guidance
  • Hysterectomy in selected cases
  • Rh D immunoglobulin for Rh D negative
  • Counselling on follow - up

Follow - up

  • Weekly β - hCG surveillance
  • Different follow - up schedules for partial and complete HM
  • Contraception until follow - up complete
  • Risk of recurrent GTD and post - molar GTN

复发性早期妊娠丢失

Care Provision

  • Specialist consultation after 3 consecutive miscarriages
  • Consider age after 2 consecutive miscarriages
  • Individualise investigation

Risk Factors

  • Similar to non - viable IUP

Lifestyle Advice

  • Cease smoking, alcohol, etc.
  • Limit caffeine, normalise BMI

Investigations

  • Standard: Blood tests, thrombophilia, TSH, karyotyping
  • Possible: Parental karyotyping, swabs, etc.

Potential Treatments

  • Progestogen for unexplained cases
  • Aspirin and heparin for APS

胎儿组织/遗体的敏感管理

Birth Registration

  • Compulsory under certain conditions

Management Options

  • Hospital cremation, private arrangements, burial on private property

Facility Responsibilities

  • Develop local protocols
  • Document arrangements

Information Provision

  • Inform parents of options
  • Respect wishes, provide support

超声标志物和记录

Sonographic Landmarks

  • Gestational sac: Earliest finding, use MSD for dating
  • Yolk sac: Differentiates gestational sac
  • Embryo and cardiac activity: Visible at specific weeks
  • Corpus luteum: Variable appearance
  • Early first - trimester dating

Standard Ultrasound Documentation

  • Approach, patient history, intrauterine and extrauterine findings

异位妊娠的甲氨蝶呤方案

Intramuscular Injection

  • Indications, dose calculation, pre - and post - dose management
  • β - hCG monitoring

Intravenous Injection

  • Indications, pre - dose preparation, dosing schedule
  • Folinic acid administration
  • β - hCG monitoring
展开全部

部分内容仅可在
临床指南app 查看下载

评论
提交评论
1099003
2024.08.21
回复
蛮不错的,用着挺舒服
/ 没有更多了 /
置顶